Your browser doesn't support javascript.
loading
Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study.
Grünwald, Viktor; Powles, Thomas; Kopyltsov, Evgeny; Kozlov, Vadim; Alonso-Gordoa, Teresa; Eto, Masatoshi; Hutson, Thomas; Motzer, Robert; Winquist, Eric; Maroto, Pablo; Keam, Bhumsuk; Procopio, Giuseppe; Wong, Shirley; Melichar, Bohuslav; Rolland, Frederic; Oya, Mototsugu; Rodriguez-Lopez, Karla; Saito, Kenichi; McKenzie, Jodi; Porta, Camillo.
Affiliation
  • Grünwald V; Interdisciplinary Genitourinary Oncology, Clinic for Urology, Clinic for Medical Oncology, University Hospital Essen, Essen, Germany. Electronic address: Viktor.Gruenwald@uk-essen.de.
  • Powles T; The Royal Free NHS Trust, London, England, UK.
  • Kopyltsov E; State Institution of Healthcare "Regional Clinical Oncology Dispensary", Omsk, Russia.
  • Kozlov V; State Budgetary Health Care Institution "Novosibirsk Regional Clinical Oncology Dispensary", Novosibirsk, Russia.
  • Alonso-Gordoa T; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Eto M; Kyushu University, Fukuoka, Japan.
  • Hutson T; Texas Oncology, Dallas, TX, USA.
  • Motzer R; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Winquist E; University of Western Ontario, London, Ontario, Canada.
  • Maroto P; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Keam B; Seoul National University Hospital, Seoul, Republic of Korea.
  • Procopio G; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy.
  • Wong S; Western Health, VIC, Australia.
  • Melichar B; Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic.
  • Rolland F; Centre René Gauducheau Centre de Lutte Contre Le Cancer Nantes, Saint-Herblain, France.
  • Oya M; Keio University School of Medicine, Tokyo, Japan.
  • Rodriguez-Lopez K; Merck & Co., Inc, Rahway, NJ, USA.
  • Saito K; Eisai Inc, Nutley, NJ, USA.
  • McKenzie J; Eisai Inc, Nutley, NJ, USA.
  • Porta C; University of Bari 'A. Moro', Bari, Italy.
Eur Urol Oncol ; 6(4): 437-446, 2023 08.
Article in En | MEDLINE | ID: mdl-36720658
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Eur Urol Oncol Year: 2023 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Eur Urol Oncol Year: 2023 Document type: Article Country of publication: Netherlands